LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Prevalence of pre-eclampsia and adverse pregnancy outcomes in women with pre-existing cardiomyopathy: a multi-centre retrospective cohort study.

Ormesher, Laura / Vause, Sarah / Higson, Suzanne / Roberts, Anna / Clarke, Bernard / Curtis, Stephanie / Ordonez, Victoria / Ansari, Faiza / Everett, Thomas R / Hordern, Claire / Mackillop, Lucy / Stern, Victoria / Bonnett, Tessa / Reid, Alice / Wallace, Suzanne / Oyekan, Ebruba / Douglas, Hannah / Cauldwell, Matthew / Reddy, Maya /
Palmer, Kirsten / Simpson, Maggie / Brennand, Janet / Minns, Laura / Freeman, Leisa / Murray, Sarah / Mary, Nirmala / Castleman, James / Morris, Katie R / Haslett, Elizabeth / Cassidy, Christopher / Johnstone, Edward D / Myers, Jenny E

Scientific reports

2023  Volume 13, Issue 1, Page(s) 153

Abstract: Pre-eclampsia is associated with postnatal cardiac dysfunction; however, the nature of this relationship remains uncertain. This multicentre retrospective cohort study aimed to determine the prevalence of pre-eclampsia in women with pre-existing cardiac ... ...

Abstract Pre-eclampsia is associated with postnatal cardiac dysfunction; however, the nature of this relationship remains uncertain. This multicentre retrospective cohort study aimed to determine the prevalence of pre-eclampsia in women with pre-existing cardiac dysfunction (left ventricular ejection fraction < 55%) and explore the relationship between pregnancy outcome and pre-pregnancy cardiac phenotype. In this cohort of 282 pregnancies, pre-eclampsia prevalence was not significantly increased (4.6% [95% C.I 2.2-7.0%] vs. population prevalence of 4.6% [95% C.I. 2.7-8.2], p = 0.99); 12/13 women had concurrent obstetric/medical risk factors for pre-eclampsia. The prevalence of preterm pre-eclampsia (< 37 weeks) and fetal growth restriction (FGR) was increased (1.8% vs. 0.7%, p = 0.03; 15.2% vs. 5.5%, p < 0.001, respectively). Neither systolic nor diastolic function correlated with pregnancy outcome. Antenatal ß blockers (n = 116) were associated with lower birthweight Z score (adjusted difference - 0.31 [95% C.I. - 0.61 to - 0.01], p = 0.04). To conclude, this study demonstrated a modest increase in preterm pre-eclampsia and significant increase in FGR in women with pre-existing cardiac dysfunction. Our results do not necessarily support a causal relationship between cardiac dysfunction and pre-eclampsia, especially given the population's background risk status. The mechanism underpinning the relationship between cardiac dysfunction and FGR merits further research but could be influenced by concomitant ß blocker use.
MeSH term(s) Humans ; Pregnancy ; Female ; Pre-Eclampsia/epidemiology ; Pregnancy Outcome ; Retrospective Studies ; Stroke Volume ; Ventricular Function, Left ; Fetal Growth Retardation/epidemiology ; Cardiomyopathies/complications ; Cardiomyopathies/epidemiology ; Heart Diseases
Language English
Publishing date 2023-01-04
Publishing country England
Document type Multicenter Study ; Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID 2615211-3
ISSN 2045-2322 ; 2045-2322
ISSN (online) 2045-2322
ISSN 2045-2322
DOI 10.1038/s41598-022-26606-z
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top